The Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) project is a consortium of nine cohorts studying the intersection of HIV infection and substance abuse.

COVID-19: C3PNO Cohort PIs

You can locate additional documents on the OwnCloud file sharing space

What is C3PNO?

The Collaborating Consortium of Cohorts Producing NIDA Opportunities (C3PNO) is the coordinating center for the National Institute on Drug Abuse (NIDA) U01 cohorts. C3PNO manages and stimulates the use of the NIDA longitudinal cohorts and addresses high priority research on HIV/AIDS in the context of substance misuse.

C3PNO is focused on cutting-edge science powered by the cohorts’ combined sample size of approximately 12,000 participants. We have assembled a team of researchers with global leadership in HIV prevention, clinical science and co-morbidities, behavioral science, immunology, modeling, and bioethics to work with NIDA program scientists to align and stimulate the highest impact science across NIDA-funded cohorts that have compiled unique repositories of varied and rich data.

Learn More About C3PNO

Submit a Concept to Request C3PNO Data

Researchers may request to use data collected by the C3PNO cohorts. You can search for available data on the Virtual Data Repository and then submit a concept to formally request data and specimens.

Submit a Concept

Recent News

NASEM Report on Measuring Sex, Gender Identity, and Sexual Orientation

Dear SGM RCC members,

The NIH Sexual & Gender Minority Research Office is excited to announce the release of a new report from the National Academies of Science, Engineering, and Medicine (NASEM) on Measuring Sex, Gender Identity, and Sexual Orientation.

Commissioned by NIH in 2020, this report provides an overview of the current evidence base, recommends specific measures for use, and identifies research opportunities within this space.

The report can be found in its pre-publication version here: https://dpcpsi.nih.gov/sgmro/reports

Read More

New Funding Opportunity: High Priority HIV and Substance Use Research

The National Institute of Health (NIH) has announced a new funding opportunity, "High Priority HIV and Substance Use Research (R01 Clinical Trial Optional)" (RFA-DA-22-040). The purpose of this initiative is to support high priority research at the intersection of HIV and substance use. This FOA invites innovative research projects with the potential to open new areas of HIV/AIDS research and/or lead to new avenues for prevention, treatment and cure of HIV among people who use drugs (PWUD). Applications submitted under this FOA are required to have a detailed research plan, preliminary data, and a clear description of the nexus with substance use.

Read More

See All News and Announcements

Questions about Specimens or Data?

Contact Us for assistance.